BRAIDWELL LP
CIK 1920938 · View on SEC EDGAR ↗
- Portfolio value
- $3.0B
- Positions
- 88
- As of
- March 31, 2026 Data as of Q1 2026
#1,102 of 8,643 by 13F value · top 12.8%
Portfolio value QoQ: -4.1% 13F does not disclose cash
- Top 10 holdings weight
- 31.56%
- Top 25 holdings weight
- 58.56%
- Positions above 1%
- 39
- Effective number of positions
- 51.6
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 19.45% Est. buys $554,316,436 · sells $1,280,159,723
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 46.2% still held
- New positions
- 24
- Increased
- 21
- Decreased
- 36
- Closed
- 23
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Sector breakdown
Healthcare
90.1%
Other/Unmapped
9.9%
Full portfolio 86 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences, Inc. - Common Stock | $147,122,490 | 5.44% | 8,256,032 | $3,913,578 | Up ×3 | ||
| HNGE Hinge Health, Inc. Class A Common Stock | $110,400,541 | 4.08% | 1,330,127 | $54,290,998 | Down ×1 | ||
| GKOS Glaukos Corporation Common Stock | $82,727,718 | 3.06% | 591,927 | $528,770 | Down ×2 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $81,136,688 | 3.00% | 1,996,965 | $7,187,823 | Down ×2 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $78,079,080 | 2.89% | 879,467 | $31,027,488 | Down ×3 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $77,824,465 | 2.88% | 654,262 | $5,809,605 | Up ×2 | ||
| NEO NeoGenomics, Inc. - Common Stock | $71,756,567 | 2.65% | 4,918,202 | $30,075,444 | Down ×1 | ||
| KOD Kodiak Sciences Inc - Common Stock | $69,633,909 | 2.58% | 1,787,318 | $306,399 | Down ×2 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $68,294,443 | 2.53% | 1,131,452 | $-9,536,541 | Down ×3 | ||
| Unknown issuer (CUSIP: 02081GAD4) | $66,183,358 | 2.45% | 69,121,000 | $2,793,835 | Up ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $59,327,800 | 2.19% | 2,451,562 | $6,579,658 | Down ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $57,957,904 | 2.14% | 594,562 | $-17,516,723 | Down ×2 | ||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $56,656,579 | 2.10% | 336,171 | $-29,253,842 | Down ×5 | ||
| ATEC Alphatec Holdings, Inc. - Common Stock | $56,496,947 | 2.09% | 6,531,439 | $32,857,699 | Up ×1 | ||
| Unknown issuer (CUSIP: 370920100) | $55,398,448 | 2.05% | 3,283,844 | $10,485,960 | Down ×1 | ||
| MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | $54,306,227 | 2.01% | 8,702,921 | $25,326,563 | Down ×1 | ||
| KRYS Krystal Biotech, Inc. - Common Stock | $47,936,138 | 1.77% | 128,975 | $812,112 | Down ×4 | ||
| HUM Humana Inc. Common Stock | $45,481,690 | 1.68% | 114,500 | Up ×1 | |||
| TMO Thermo Fisher Scientific Inc Common Stock | $44,819,077 | 1.66% | 89,395 | $-851,433 | Down ×1 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $43,363,951 | 1.60% | 378,163 | $15,248,662 | Up ×1 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $42,316,642 | 1.57% | 381,128 | $15,301,325 | Up ×1 | ||
| GLTO Galecto, Inc. - Common Stock | $42,146,006 | 1.56% | 1,620,377 | $18,969,495 | Up ×1 | ||
| ACAD ACADIA Pharmaceuticals Inc. - Common Stock | $41,653,895 | 1.54% | 1,646,399 | $-13,354,995 | Down ×1 | ||
| BTSG BrightSpring Health Services, Inc. - Common Stock | $41,617,554 | 1.54% | 596,753 | $-1,698,153 | Down ×2 | ||
| TMDX TransMedics Group, Inc. - Common Stock | $40,497,270 | 1.50% | 609,715 | $7,752,511 | Up ×2 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $39,240,576 | 1.45% | 710,880 | $-5,309,564 | Down ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $36,477,770 | 1.35% | 2,797,375 | $25,999,496 | Up ×1 | ||
| CDNA CareDx, Inc. - Common Stock | $34,787,157 | 1.29% | 1,220,602 | $-2,938,658 | Down ×1 | ||
| MAZE Maze Therapeutics, Inc. - Common Stock | $34,018,794 | 1.26% | 1,140,040 | Up ×1 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $33,964,304 | 1.26% | 483,822 | $-5,418,189 | Down ×1 | ||
| ACHC Acadia Healthcare Company, Inc. - Common Stock | $33,707,816 | 1.25% | 1,141,477 | $18,600,215 | Up ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $33,063,203 | 1.22% | 473,617 | $17,039,866 | Up ×1 | ||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $31,766,892 | 1.18% | 2,126,298 | $6,123,457 | Up ×1 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $31,217,016 | 1.15% | 1,286,769 | $4,080,143 | Down ×2 | ||
| INSP Inspire Medical Systems, Inc. Common Stock | $30,226,398 | 1.12% | 677,570 | $-4,722,663 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $30,107,283 | 1.11% | 1,629,182 | Up ×1 | |||
| Unknown issuer (CUSIP: 010911105) | $29,365,099 | 1.09% | 1,083,983 | Up ×1 | |||
| DHR Danaher Corporation Common Stock | $28,691,431 | 1.06% | 150,627 | $2,275,032 | Up ×2 | ||
| ISRG Intuitive Surgical, Inc. - Common Stock | $27,892,082 | 1.03% | 70,137 | $-7,741,062 | Down ×3 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $26,472,868 | 0.98% | 278,164 | ||||
| Unknown issuer (CUSIP: 05348Y105) | $26,381,923 | 0.98% | 801,395 | Up ×1 | |||
| AVAH Aveanna Healthcare Holdings Inc. - Common Stock | $26,267,958 | 0.97% | 3,065,106 | $12,077,379 | Up ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $25,321,992 | 0.94% | 1,033,129 | $4,323,725 | Down ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $25,077,360 | 0.93% | 587,567 | $3,336,556 | Up ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $24,232,307 | 0.90% | 564,724 | $3,158,867 | Up ×1 | ||
| RGEN Repligen Corporation - Common Stock | $24,163,524 | 0.89% | 177,100 | $18,567,074 | Up ×1 | ||
| ZURA Zura Bio Limited - Class A Ordinary shares | $23,483,741 | 0.87% | 3,980,295 | $-250,744 | Down ×1 | ||
| GH Guardant Health, Inc. - Common Stock | $22,181,936 | 0.82% | 147,850 | $-23,976,461 | Down ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $21,897,150 | 0.81% | 3,155,209 | $9,134,741 | Up ×1 | ||
| NTRA Natera, Inc. - Common Stock | $21,580,275 | 0.80% | 79,500 | $-4,218,435 | Down ×1 | ||
| KIDS OrthoPediatrics Corp. - Common Stock | $21,050,078 | 0.78% | 1,100,370 | $3,587,206 | |||
| ELV Elevance Health, Inc. Common Stock | $20,867,951 | 0.77% | 53,960 | $2,694,031 | Down ×1 | ||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $20,518,438 | 0.76% | 596,900 | $-5,666,999 | Down ×2 | ||
| DYN Dyne Therapeutics, Inc. - Common Stock | $20,468,692 | 0.76% | 921,598 | $-10,025,932 | Down ×1 | ||
| Unknown issuer (CUSIP: 64049MAB6) | $16,885,250 | 0.62% | 18,011,000 | $-74,963,365 | Down ×1 | ||
| IMCR Immunocore Holdings plc - American Depositary Shares | $16,552,132 | 0.61% | 521,327 | Up ×1 | |||
| Unknown issuer (CUSIP: 759916AD1) | $16,445,954 | 0.61% | 16,000,000 | $-82,231,046 | Down ×1 | ||
| ARGX argenx SE - American Depositary Shares | $16,428,023 | 0.61% | 17,707 | $-45,598,682 | Down ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $16,247,598 | 0.60% | 436,646 | $-26,767,323 | Down ×2 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $15,923,358 | 0.59% | 5,919,464 | Up ×1 | |||
| MNKD MannKind Corporation - Common Stock | $14,732,908 | 0.54% | 3,458,429 | Up ×1 | |||
| QURE uniQure N.V. - Ordinary Shares | $13,894,091 | 0.51% | 301,652 | Up ×1 | |||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $13,649,261 | 0.50% | 2,922,754 | $131,961 | Down ×2 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $13,153,468 | 0.49% | 1,214,540 | $-1,138,799 | Up ×1 | ||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $11,755,417 | 0.43% | 183,822 | $-1,366,517 | Down ×6 | ||
| OCS Oculis Holding AG - Ordinary shares | $11,570,118 | 0.43% | 834,183 | Up ×1 | |||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $11,333,021 | 0.42% | 2,142,348 | $4,961,336 | Up ×1 | ||
| Unknown issuer (CUSIP: 81221K108) | $10,860,000 | 0.40% | 500,000 | Up ×1 | |||
| VOR Vor Biopharma Inc. - Common Stock | $10,550,845 | 0.39% | 573,104 | $2,223,597 | Up ×1 | ||
| SRZN Surrozen, Inc. - Common Stock | $10,140,040 | 0.38% | 390,753 | $-1,398,353 | Down ×2 | ||
| Unknown issuer (CUSIP: 4525EP200) | $9,913,804 | 0.37% | 645,010 | Up ×1 | |||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $9,540,000 | 0.35% | 900,000 | $270,000 | |||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $9,258,059 | 0.34% | 116,762 | $-568,369 | Down ×1 | ||
| DGX Quest Diagnostics Incorporated Common Stock | $9,156,240 | 0.34% | 43,200 | Up ×1 | |||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $9,144,961 | 0.34% | 795,214 | Up ×1 | |||
| TENX Tenax Therapeutics, Inc. - Common Stock | $8,503,195 | 0.31% | 584,412 | Up ×1 | |||
| Unknown issuer (CUSIP: 485925101) | $7,155,000 | 0.26% | 300,000 | Up ×1 | |||
| Unknown issuer (CUSIP: G0375M101) | $7,112,000 | 0.26% | 700,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 423494103) | $5,876,800 | 0.22% | 160,000 | Up ×1 | |||
| GHRS GH Research PLC - Ordinary Shares | $5,570,611 | 0.21% | 207,240 | Up ×1 | |||
| WAT Waters Corporation Common Stock | $5,265,562 | 0.19% | 14,040 | Up ×1 | |||
| Unknown issuer (CUSIP: G75226103) | $4,280,000 | 0.16% | 400,000 | Up ×1 | |||
| Unknown issuer (CUSIP: G50765109) | $2,840,000 | 0.11% | 250,000 | Up ×1 | |||
| LUNG Pulmonx Corporation - Common Stock | $978,303 | 0.04% | 752,541 | $7,525 | |||
| VYNE VYNE Therapeutics Inc. - Common Stock | $596,091 | 0.02% | 916,077 | $48,735 | |||
| CYCN Cyclerion Therapeutics, Inc. - Common Stock | $531,857 | 0.02% | 156,890 | Up ×1 | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
| Security | Value | % of portfolio | Streak |
|---|---|---|---|
| CAI | $147,122,490 | 5.44% | up ×3 |
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| HUM | $45,481,690 | 114,500 | 1.68% |
| MAZE | $34,018,794 | 1,140,040 | 1.26% |
| AVTX | $30,107,283 | 1,629,182 | 1.11% |
| Unknown issuer (CUSIP: 010911105) | $29,365,099 | 1,083,983 | 1.09% |
| ORKA | $26,472,868 | 278,164 | 0.98% |
| Unknown issuer (CUSIP: 05348Y105) | $26,381,923 | 801,395 | 0.98% |
| IMCR | $16,552,132 | 521,327 | 0.61% |
| OVID | $15,923,358 | 5,919,464 | 0.59% |
| MNKD | $14,732,908 | 3,458,429 | 0.54% |
| QURE | $13,894,091 | 301,652 | 0.51% |
| OCS | $11,570,118 | 834,183 | 0.43% |
| Unknown issuer (CUSIP: 81221K108) | $10,860,000 | 500,000 | 0.40% |
| Unknown issuer (CUSIP: 4525EP200) | $9,913,804 | 645,010 | 0.37% |
| DGX | $9,156,240 | 43,200 | 0.34% |
| ANL | $9,144,961 | 795,214 | 0.34% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| HNGE | Trimmed | -125K | +$54.3M |
| ARGX | Trimmed | -67K | -$45.6M |
| ATEC | Bought more | +4.4M | +$32.9M |
| SYRE | Trimmed | -53K | +$31.0M |
| NEO | Trimmed | -699K | +$30.1M |
| NBIX | Trimmed | -316K | -$29.3M |
| CLDX | Trimmed | -919K | -$26.8M |
| CLYM | Bought more | +1.3M | +$26.0M |
| MRVI | Trimmed | -1.5M | +$25.3M |
| GH | Trimmed | -352K | -$24.0M |
2 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| CNTA | June 30, 2026 | 1,986,768 | $78,914,425 | No longer tracked |
| NUVL | June 30, 2026 | 700,429 | $71,758,951 | No longer tracked |
| CGON | June 30, 2026 | 984,783 | $66,650,113 | 10.5% |
| ALGN | March 31, 2026 | 381,004 | $59,493,775 | 0.8% |
| GH | Sept. 30, 2025 | 837,800 | $43,599,112 | 157.7% |
| AVDL | March 31, 2025 | 4,105,726 | $43,151,180 | No longer tracked |
| APGE | June 30, 2026 | 478,667 | $40,289,401 | 1.5% |
| FNA | March 31, 2025 | 3,834,809 | $39,613,577 | No longer tracked |
| BPMC | June 30, 2025 | 439,968 | $38,941,568 | No longer tracked |
| BNTX | March 31, 2025 | 309,865 | $35,309,117 | 23.8% |
| PEN | June 30, 2026 | 105,352 | $34,594,436 | 3.4% |
| SLNO | June 30, 2026 | 959,259 | $32,115,991 | No longer tracked |
| RAPT | March 31, 2026 | 929,694 | $31,488,736 | No longer tracked |
| KROS | March 31, 2025 | 1,894,439 | $29,988,969 | 6.6% |
| GMED | Dec. 31, 2025 | 498,000 | $28,520,460 | 1.1% |
| ILMN | June 30, 2026 | 229,215 | $28,253,041 | 13.8% |
| LEGN | March 31, 2026 | 1,298,142 | $28,221,607 | 25.3% |
| BCAX | June 30, 2025 | 2,162,803 | $28,181,323 | 181.7% |
| BMRN | June 30, 2026 | 497,020 | $28,076,660 | 19.6% |
| ESTA | June 30, 2026 | 463,600 | $26,323,208 | -11.6% |
| IMTX | March 31, 2025 | 3,503,965 | $24,913,191 | 104.7% |
| GERN | March 31, 2025 | 7,006,315 | $24,802,355 | -0.9% |
| THC | Dec. 31, 2025 | 121,700 | $24,709,968 | 38.9% |
| FULC | June 30, 2026 | 3,134,922 | $24,044,852 | 7.2% |
| TERN | March 31, 2026 | 575,321 | $23,242,968 | No longer tracked |
| EXAS | Dec. 31, 2025 | 414,600 | $22,682,766 | No longer tracked |
| AKRO | Dec. 31, 2025 | 475,400 | $22,571,992 | No longer tracked |
| ATEC | Dec. 31, 2025 | 1,514,604 | $22,022,342 | -53.1% |
| CVS | June 30, 2026 | 290,700 | $20,878,074 | -7.6% |
| BRKR | March 31, 2025 | 353,200 | $20,704,584 | 43.6% |
| BIIB | March 31, 2026 | 115,700 | $20,362,043 | 19.3% |
| VKTX | Dec. 31, 2025 | 759,455 | $19,958,477 | -1.8% |
| EXAS | March 31, 2025 | 353,000 | $19,835,070 | No longer tracked |
| APLS | Sept. 30, 2025 | 1,121,034 | $19,405,099 | No longer tracked |
| TARS | June 30, 2026 | 265,715 | $18,639,907 | 15.1% |
| MDGL | Sept. 30, 2025 | 60,781 | $18,394,762 | 16.7% |
| PCVX | March 31, 2025 | 222,424 | $18,207,629 | 64.8% |
| RARE | Dec. 31, 2025 | 588,700 | $17,708,096 | 14.8% |
| VTYX | March 31, 2026 | 1,920,255 | $17,339,903 | No longer tracked |
| ENGN | June 30, 2026 | 2,456,870 | $16,731,285 | 1.2% |
| ASND | June 30, 2025 | 106,713 | $16,632,288 | 48.4% |
| SRPT | Dec. 31, 2025 | 832,100 | $16,034,567 | -9.0% |
| UNH | Sept. 30, 2025 | 49,400 | $15,411,318 | 14.4% |
| DAWN | Dec. 31, 2025 | 2,181,598 | $15,380,266 | No longer tracked |
| JSPR | March 31, 2025 | 714,658 | $15,279,388 | -82.3% |
| SRPT | June 30, 2025 | 234,500 | $14,965,790 | 14.5% |
| RNA | Dec. 31, 2025 | 331,907 | $14,461,188 | -81.8% |
| EHC | Dec. 31, 2025 | 113,335 | $14,395,812 | 15.8% |
| CADL | March 31, 2025 | 1,600,000 | $13,888,000 | 125.5% |
| ICLR | March 31, 2026 | 73,370 | $13,369,481 | 56.9% |
| RCUS | March 31, 2025 | 802,100 | $11,943,269 | 293.5% |
| TGTX | June 30, 2026 | 358,800 | $11,919,336 | -7.0% |
| CELC | Sept. 30, 2025 | 884,306 | $11,805,485 | 92.1% |
| REPL | Dec. 31, 2025 | 2,750,092 | $11,522,885 | 60.2% |
| CNC | June 30, 2026 | 330,000 | $10,804,200 | 1.3% |
| CMPX | June 30, 2026 | 1,965,106 | $10,395,411 | 13.5% |
| IRWD | June 30, 2025 | 6,622,584 | $9,735,198 | 514.6% |
| SION | Dec. 31, 2025 | 314,013 | $9,235,122 | -85.2% |
| AMLX | Dec. 31, 2025 | 612,841 | $8,328,509 | 211.1% |
| RVMD | June 30, 2026 | 84,900 | $8,256,525 | 16.4% |
| RLMD | March 31, 2026 | 1,582,257 | $7,642,301 | -29.8% |
| CGEM | June 30, 2025 | 980,773 | $7,424,452 | 187.9% |
| GRAL | June 30, 2026 | 142,755 | $7,377,578 | 11.1% |
| XNCR | March 31, 2026 | 459,166 | $7,029,831 | 119.7% |
| CSTL | March 31, 2026 | 177,183 | $6,892,419 | 23.1% |
| FDMT | March 31, 2025 | 1,225,448 | $6,825,745 | 381.3% |
| DNTH | June 30, 2025 | 375,355 | $6,808,940 | 522.5% |
| RPRX | Dec. 31, 2025 | 182,068 | $6,423,359 | 57.0% |
| NVRO | March 31, 2025 | 1,698,768 | $6,319,417 | No longer tracked |
| DNLI | June 30, 2026 | 296,324 | $5,689,421 | -2.6% |
| HROW | June 30, 2026 | 156,419 | $5,515,334 | -1.9% |
| CBLL | March 31, 2025 | 210,000 | $5,434,800 | 30.3% |
| ADPT | March 31, 2026 | 311,991 | $5,066,734 | 84.4% |
| MTSR | June 30, 2025 | 175,000 | $4,763,500 | No longer tracked |
| RVTY | June 30, 2026 | 48,400 | $4,240,324 | 8.8% |
| CBIO | Sept. 30, 2025 | 261,504 | $4,220,675 | 46.3% |
| BLLN | March 31, 2026 | 50,000 | $4,092,000 | 14.2% |
| AARD | June 30, 2025 | 500,000 | $3,755,000 | -47.6% |
| AVTE | June 30, 2025 | 1,440,499 | $3,615,652 | No longer tracked |
| CELC | June 30, 2026 | 29,198 | $3,332,660 | -9.3% |
| PRAX | June 30, 2026 | 9,976 | $3,214,167 | 10.3% |
| ORKA | March 31, 2026 | 84,795 | $2,570,136 | 123.3% |
| KPTI | March 31, 2026 | 303,370 | $2,232,803 | -64.3% |
| BBNX | June 30, 2025 | 140,000 | $1,713,600 | 39.7% |
| HTFL | Dec. 31, 2025 | 50,000 | $1,683,000 | 59.5% |
| SKYE | June 30, 2025 | 825,732 | $1,312,914 | -91.9% |
| PTGX | March 31, 2025 | 20,109 | $776,207 | 226.1% |
| VRDN | March 31, 2025 | 34,094 | $653,582 | 81.5% |
| TRVI | June 30, 2025 | 72,083 | $453,402 | 244.2% |